Position in CRDF
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$26,588
-$880 QoQ
Shares Held
20,453
+20.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 104 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $23,861,614 across 48 Biotechnology names. CRDF ranks #44 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
36,050 | $4,086,628 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,048 | $3,997,683 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,325 | $2,696,810 | |
| 4 | EXEL |
Exelixis, Inc.
|
40,712 | $2,215,139 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,898 | $1,474,444 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
17,246 | $986,816 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,466 | $649,112 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
7,463 | $648,907 |
All Filings in CRDF
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,588 | 20,453 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $27,468 | 16,956 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $34,002 | 16,506 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $51,984 | 16,503 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $51,810 | 16,500 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||